Back to Search Start Over

Characterization and Differential Cytotoxicity of Gramicidin Nanoparticles Combined with Cationic Polymer or Lipid Bilayer.

Authors :
Pérez-Betancourt Y
Zaia R
Evangelista MF
Ribeiro RT
Roncoleta BM
Mathiazzi BI
Carmona-Ribeiro AM
Source :
Pharmaceutics [Pharmaceutics] 2022 Sep 27; Vol. 14 (10). Date of Electronic Publication: 2022 Sep 27.
Publication Year :
2022

Abstract

Gramicidin (Gr) nanoparticles (NPs) and poly (diallyl dimethyl ammonium) chloride (PDDA) water dispersions were characterized and evaluated against Gram-positive and Gram-negative bacteria and fungus. Dynamic light scattering for sizing, zeta potential analysis, polydispersity, and colloidal stability over time characterized Gr NPs/PDDA dispersions, and plating and colony-forming units counting determined their microbicidal activity. Cell viabilities of Staphylococcus aureus , Pseudomonas aeruginosa , and Candida albicans in the presence of the combinations were reduced by 6, 7, and 7 logs, respectively, at 10 μM Gr/10 μg·mL <superscript>-1</superscript> PDDA, 0.5 μM Gr/0. 5μg·mL <superscript>-1</superscript> PDDA, and 0.5 μM Gr/0.5 μg·mL <superscript>-1</superscript> PDDA, respectively. In comparison to individual Gr doses, the combinations reduced doses by half ( S. aureus ) and a quarter ( C. albicans ); in comparison to individual PDDA doses, the combinations reduced doses by 6 times ( P. aeruginosa ) and 10 times ( C. albicans ). Gr in supported or free cationic lipid bilayers reduced Gr activity against S. aureus due to reduced Gr access to the pathogen. Facile Gr NPs/PDDA disassembly favored access of each agent to the pathogen: PDDA suctioned the pathogen cell wall facilitating Gr insertion in the pathogen cell membrane. Gr NPs/PDDA differential cytotoxicity suggested the possibility of novel systemic uses for the combination.

Details

Language :
English
ISSN :
1999-4923
Volume :
14
Issue :
10
Database :
MEDLINE
Journal :
Pharmaceutics
Publication Type :
Academic Journal
Accession number :
36297488
Full Text :
https://doi.org/10.3390/pharmaceutics14102053